In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K/A | S-1/A | S-1/A |
Revenues: |
TPT MedTech and QuickLABS | 0.5 | 0.0 | | | | | |
TPT SpeedConnect | 7.6 | 10.0 | 8.0 | | | | |
Other | 1.9 | 1.1 | 2.2 | | | | |
Total revenues [+] | 10.0 | 11.1 | 10.2 | 0.9 | 2.1 | | 3.2 |
Products | 0.6 | 0.0 | | | | | 0.8 |
Services | 9.5 | 11.1 | | | | | 2.4 |
Revenue growth [+] | -9.6% | 8.6% | 989.8% | -55.7% | | | |
TPT MedTech and QuickLABS | 1555.3% | | | | | | |
TPT SpeedConnect | -23.9% | 24.4% | | | | | |
BlueCollar | | | 784.8% | | | | |
Cost of goods sold [+] | 7.8 | 7.2 | 5.9 | 1.7 | 2.2 | | 4.0 |
Cost of product sales | | | | | | | 0.8 |
Cost of services | | | | | | | 1.0 |
Sales commissions and fees | | | | | | | 0.5 |
Gross profit | 2.2 | 3.9 | 4.3 | -0.8 | 0.0 | | -0.8 |
Gross margin | 22.2% | 35.2% | 42.1% | -86.6% | -2.3% | | -26.3% |
Selling, general and administrative [+] | 6.5 | 6.6 | 5.0 | 3.4 | 2.0 | | 1.3 |
Sales and marketing | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | | 0.3 |
General and administrative [+] | 6.5 | 6.6 | 4.9 | 3.3 | 1.8 | | 1.0 |
Wages and related expenses | 2.6 | 2.5 | 1.5 | 0.8 | 0.5 | | |
General and administrative expenses | 2.4 | 2.0 | 1.5 | 0.8 | 0.7 | | 1.0 |
Professional fees | 1.5 | 2.1 | 1.9 | 1.7 | 0.6 | | |
Research and development | | 1.0 | | | | | |
Other operating expenses | | | | | 0.3 | | 2.7 |
EBITDA [+] | -4.3 | -3.7 | -0.7 | -4.2 | -2.3 | | -3.7 |
EBITDA growth | 15.0% | 431.2% | -83.2% | 79.9% | | | |
EBITDA margin | -42.6% | -33.5% | -6.8% | -445.1% | -109.6% | | -116.1% |
Depreciation | 0.7 | 1.1 | 0.6 | 0.2 | 0.2 | | 0.6 |
EBITA | -5.0 | -4.8 | -1.3 | -4.4 | -2.5 | | -4.4 |
EBITA margin | -49.4% | -43.0% | -12.6% | -467.9% | -117.9% | | -136.1% |
Amortization of intangibles | 0.7 | 0.7 | 0.9 | 0.8 | 1.0 | | 0.5 |
EBIT [+] | -5.7 | -5.5 | -2.2 | -5.1 | -3.5 | | -4.9 |
EBIT growth | 3.3% | 154.8% | -58.0% | 48.8% | | | |
EBIT margin | -56.7% | -49.6% | -21.1% | -549.0% | -163.5% | | -151.6% |
Non-recurring items [+] | 1.0 | 2.7 | 0.9 | | -0.5 | | |
Asset impairment | 1.0 | 2.7 | 0.9 | | -0.5 | | |
Interest expense | 2.6 | 1.5 | 3.6 | 0.2 | 0.2 | | 0.1 |
Interest expense | 2.6 | 1.5 | 3.6 | 0.2 | 0.2 | | 0.1 |
Other income (expense), net [+] | 5.2 | 1.6 | -7.3 | | -0.6 | | |
Gain (loss) on debt retirement | 8.5 | 1.3 | | | | | |
Unrealized gain/loss on derivatives | -3.5 | 1.1 | | | | | |
Other | -0.3 | | | | | | |
Pre-tax income | -4.1 | -8.1 | -14.0 | -5.4 | -3.8 | | -5.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | 0.0% |
Minority interest | 0.1 | 0.0 | | | | | |
Net income | -4.0 | -8.1 | -14.0 | -5.4 | -3.8 | | -5.0 |
Net margin | -40.1% | -72.8% | -137.4% | -573.9% | -180.0% | | -154.9% |
|
Basic EPS [+] | $0.00 | ($0.01) | ($0.10) | ($0.04) | ($0.03) | | |
Growth | -58.6% | -89.0% | 152.3% | 41.2% | | | |
Diluted EPS [+] | $0.00 | ($0.01) | ($0.10) | ($0.04) | ($0.03) | | |
Growth | -58.6% | -89.0% | 152.3% | 41.2% | | | |
|
Shares outstanding (basic) [+] | 889.4 | 740.2 | 141.6 | 137.0 | 137.0 | | |
Growth | 20.2% | 422.7% | 3.4% | 0.0% | | | |
Shares outstanding (diluted) [+] | 889.4 | 740.2 | 141.6 | 137.0 | 137.0 | | |
Growth | 20.2% | 422.7% | 3.4% | 0.0% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |